Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting immunostaining in relation to complex human pathologies.TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding. Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
E3 ubiquitin-protein ligase which mediates ubiquitination and subsequent proteasomal degradation of target proteins. Regulates apoptosis by catalyzing the polyubiquitination and degradation of MCL1. Mediates monoubiquitination of DNA polymerase beta (POLB) at 'Lys-41', 'Lys-61' and 'Lys-81', thereby playing a role in base-excision repair. Also ubiquitinates the p53/TP53 tumor suppressor and core histones including H1, H2A, H2B, H3 and H4. Binds to an upstream initiator-like sequence in the preprodynorphin gene. Regulates neural differentiation and proliferation by catalyzing the polyubiquitination and degradation of MYCN. May regulate abundance of CDC6 after DNA damage by polyubiquitinating and targeting CDC6 to degradation.
|Gene Name:||HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase|
|Synonyms:||HUWE1, ARF-binding protein 1, ARF-BP1, BJ-HCC-24 tumor antigen, Ib772, KIAA0312, LASU1, Mcl-1 ubiquitin ligase E3, HECTH9, MULE, HSPC272, KIAA1578, URE-B1, UREB1, URE-binding protein 1, HECT domain protein LASU1, Large structure of UREB1|
|Target Sequences:||NM_031407 NP_113584.3 Q7Z6Z7|
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.